Financial News

Financial Report: West

Contract-Manufactured Products segment up 13% in the quarter

By: Kristin Brooks

Managing Editor, Contract Pharma

West
3Q Revenues: $398.2 million (+6%)
3Q Earnings: $51.0 million (+36%)
YTD Revenues: $1.2 billion (+5%)
YTD Earnings: $150.7 million (+44%)
Comments: Proprietary Products segment sales were $308.9 million in the quarter, up 4%. Biologics sales growth was lower than anticipated due to customers in Puerto Rico unable to receive shipments, which had a negative impact sales of approximately $2 million. Contract-Manufactured Products segment sales were $89.3 million, up 13%.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters